Central retinal vein occlusion;Zentralvenenverschlüsse

Klinische Monatsblatter fur Augenheilkunde

Volumn 224, Issue 9, 2007, Pages

  Lang, Gabriele E ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BEVACIZUMAB; PEGAPTANIB; PENTOXIFYLLINE; RANIBIZUMAB;

CENTRAL RETINA VEIN OCCLUSION; ELECTRORETINOGRAM; EXTRAVASATION; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; HUMAN; IRIS RUBEOSIS; LASER COAGULATION; PATHOGENESIS; PREVALENCE; RECANALIZATION; RISK FACTOR; SHORT SURVEY; VITRECTOMY;

COMORBIDITY; EPIRETINAL MEMBRANE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IRIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETINAL ARTERY OCCLUSION; RETINAL HEMORRHAGE; RETINAL VEIN OCCLUSION; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISION DISORDERS;

EID: 35348857421     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-965673     Document Type: Short Survey

References (13)

1. Central Retinal Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central retinal vein occlusion: the Central Retinal Vein Occlusion Study Group N report. Ophthalmol 1995; 102: 1434-1444
2. Central Retinal Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115: 486-491
3. Evaluation of grid pattern photocoagulation for macular edema in central retinal vein occlusion: the Central Retinal Vein Occlusion Study Group M report. Ophthalmol 1995; 102: 1425-1433
4. De Sanctis MT, Cesarone MR, Belcaro G et al. Treatment of retinal vein thrombosis with pentoxifylline: a controlled randomized trial. Angiol 2002; 53: 35-38
5. Gahzi NG, Noureddine B, Haddad RS et al. Intravitreal tissue plasminogen activator in the management in the mamgement of central retinal vein occlusion. Retina 2003; 23: 780-784
6. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G, Soubrane G. Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001; 239: 909-914
7. Mester U. Surgical approach to retinal vein occlusion. Klin Monatsbl Augenheilkd 2005; 222: 299-308
8. Mruthyunjaya P, Fekrat S. Central retinal vein occlusion. In: Ryan SJ. Retina, 4th ed., Vol. 2. Baltimore, Maryland, USA: Mosby, 2006: 1339-1348
9. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion. Ophthalmol 2007; 114: 507-519
10. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE. Radial optic neurotomy for central retinal vein occlusion. Retina 2006; 26: 297-305
11. Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion - result of a prospective case series. Graefes Arch Clin Exp Ophthalmol 2007; 245: im Druck
12. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmol 2001; 108: 2249-2257
13. Wolf S, Arend O, Bertram B et al. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective tandomized study. Graefes Arch Clin Ophthalmol 1994; 232: 33-39